Cormark Has Negative Outlook for OTC:GTBIF FY2024 Earnings

Green Thumb Industries Inc. (OTC:GTBIF) – Cormark cut their FY2024 earnings per share (EPS) estimates for Green Thumb Industries in a report issued on Monday, November 11th. Cormark analyst J. Pytlak now expects that the company will post earnings per share of $0.33 for the year, down from their prior estimate of $0.38. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share. Cormark also issued estimates for Green Thumb Industries’ FY2025 earnings at $0.40 EPS.

A number of other equities research analysts also recently issued reports on GTBIF. Craig Hallum raised shares of Green Thumb Industries to a “strong-buy” rating in a research note on Monday, September 16th. Roth Capital upgraded Green Thumb Industries to a “strong-buy” rating in a research note on Sunday, November 10th. Finally, Ventum Cap Mkts raised Green Thumb Industries to a “strong-buy” rating in a research note on Tuesday, August 6th.

Green Thumb Industries Trading Down 4.2 %

GTBIF stock opened at $9.29 on Wednesday. The stock has a market cap of $1.97 billion, a price-to-earnings ratio of 34.42 and a beta of 1.40. Green Thumb Industries has a one year low of $7.50 and a one year high of $16.33. The firm’s 50 day moving average price is $10.24.

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.